Cargando…
Histamine receptors and COVID-19
OBJECTIVE: Reports that the over-the-counter histamine H(2) receptor antagonist famotidine could help treat the novel coronavirus disease (COVID-19) appeared from April 2020. We, therefore, examined reports on interactions between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and hist...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7673069/ https://www.ncbi.nlm.nih.gov/pubmed/33206207 http://dx.doi.org/10.1007/s00011-020-01422-1 |